coronavirus
strain
associ
variou
respiratori
ill
rang
selfresolv
common
cold
sever
pneumonia
although
chronic
underli
condit
major
determin
sever
respiratori
viru
infect
data
coronavirusrel
pneumonia
immunocompromis
patient
avail
report
welldocu
case
pneumonia
relat
coronaviru
differ
clinic
present
diagnosi
made
basi
viral
cultur
electron
microscopi
find
exhibit
typic
crownlik
particl
amplif
viral
genom
revers
transcriptasepolymeras
chain
reaction
basi
report
coronavirus
consid
potenti
caus
microorgan
pneumonia
immunocompromis
patient
pulmonari
complic
occur
frequent
immunocompromis
patient
treat
hematolog
malign
cover
wide
rang
etiolog
includ
infect
bacteri
fungal
parasit
viral
origin
pulmonari
edema
diffus
alveolar
hemorrhag
drugor
radiationinduc
toxic
graftversushost
diseas
bronchiol
obliteran
addit
entiti
name
idiopath
pneumonia
syndrom
defin
diffus
lung
injuri
etiolog
identifi
frequent
recogn
hematopoiet
stem
cell
transplant
hsct
larg
number
case
pneumonia
may
relat
unrecogn
viral
infect
absenc
routin
screen
reliabl
diagnost
procedur
number
probabl
underestim
coronavirus
positivesens
singlestrand
rna
virus
whose
particl
irregularli
shape
outer
envelop
carri
distinct
clubshap
peplom
give
crownlik
appear
two
coronaviru
strain
known
involv
human
diseas
mainli
common
cold
syndrom
also
pneumonia
coronavirus
recent
becam
subject
particular
interest
novel
strain
identifi
primari
agent
associ
worldwid
outbreak
sever
acut
respiratori
syndrom
sar
report
welldocu
case
coronavirusrel
pneumonia
immunocompromis
patient
treat
hematolog
malign
diagnost
strategi
combin
viral
cultur
cell
rtpcr
control
hybrid
strainspecif
probe
white
man
admit
hospit
fever
weight
loss
continu
nonproduct
cough
three
year
previous
patient
treat
stage
ii
larg
b
cell
nonhodgkin
lymphoma
accord
french
protocol
diseas
progress
underw
highdos
chemotherapi
intensif
support
autolog
hsct
longterm
complet
remiss
achiev
relaps
occur
year
transplant
treat
highdos
sequenti
salvag
therapi
combin
etoposid
ifosfamid
mitoxantron
cytarabin
ten
day
second
cycl
chemotherapi
dissemin
cutan
vesicl
appear
suggest
varicella
zoster
viru
vzv
associ
erupt
respiratori
symptom
abnorm
chest
radiograph
find
present
patient
success
treat
intraven
acyclovir
mgkg
everi
h
day
complet
acyclovir
treatment
patient
develop
febril
nonproduct
cough
without
dyspnea
chest
radiograph
show
bilater
interstiti
syndrom
confirm
ct
scan
show
dissemin
micronodular
opac
arteri
blood
ga
valu
breath
room
air
normal
laboratori
find
follow
wbc
count
cellsmm
polymorphonuclear
cell
lymphocyt
platelet
count
plateletsmm
liver
enzym
level
normal
sputum
sampl
neg
legionella
speci
subject
direct
immunofluoresc
bacteri
cultur
sputum
sampl
show
growth
result
test
serum
sampl
aspergillu
galactomannan
antigen
also
neg
follow
failur
empir
antibiot
treatment
piperacillin
ciprofloxacin
fiberopt
bronchoalveolar
lavag
bal
perform
middl
lobe
cytolog
analysi
specimen
bal
fluid
show
nucleat
cellsmm
polymorphonuclear
cell
macrophag
lymphocyt
identifi
tcell
lymphocyt
flow
cytometri
analysi
cell
cell
find
extens
microbiolog
direct
examin
cultur
remain
neg
bacteria
mycobacteria
fungi
parasit
pneumocysti
carinii
result
immunofluoresc
assay
multipl
respiratori
virus
respiratori
synciti
viru
rsv
parainfluenza
virus
ii
iii
adenoviru
influenza
virus
b
herp
virus
herp
simplex
viru
hsv
vzv
immunoperoxydas
stain
cytomegaloviru
cmv
neg
specimen
bal
fluid
result
pcr
test
perform
specimen
bal
fluid
vzvspecif
primer
also
neg
viral
cultur
show
growth
human
amniot
cell
vero
cell
line
contrast
cytopath
effect
observ
human
hepatoma
cell
line
cultur
specimen
bal
fluid
unrecogn
influenza
parainfluenza
virus
rsv
adenoviru
measl
enteroviru
vzvspecif
antibodi
electron
microscopi
find
identifi
coronalik
particl
cultur
supernat
medium
figur
rtpcr
test
perform
infect
noninfect
cell
use
strainspecif
primer
locat
gene
human
coronavirus
confirm
diagnosi
type
viru
strain
strain
figur
rtpcr
product
also
character
sequenc
viru
hybrid
specif
probe
dna
enzym
immunoassay
presenc
coronaviru
rna
bal
fluid
specimen
confirm
amplif
sequenc
wherea
result
rtpcr
perform
oligonucleotid
primer
deriv
gene
sequenc
strain
remain
neg
result
cytopath
effect
seroneutr
test
show
low
initi
antibodi
respons
signific
differ
antibodi
respons
preinfect
serum
sampl
titer
postinfect
serum
sampl
titer
serolog
studi
respiratori
virus
adenoviru
myxoviru
paramyxoviru
rsv
cmv
vzv
epsteinbarr
viru
hsv
mycoplasma
speci
reveal
signific
increas
serum
sampl
antibodi
titer
result
serolog
test
chlamydia
bacteria
aspergillu
remain
neg
outcom
spontan
favor
fever
disappear
day
without
modif
antibiot
regimen
consist
improv
chest
radiograph
find
case
studi
femal
patient
admit
intens
care
unit
icu
acut
respiratori
failur
day
allogen
bone
marrow
transplant
treat
mechlorethamin
vincristin
procarbazin
prednison
mopp
chemotherapi
combin
year
previous
hodgkin
lymphoma
cervic
mediastin
lymphadenopathi
first
relaps
pulmonari
gastric
involv
treat
highdos
chemotherapi
intensif
melphalan
misulban
cytarabin
support
autolog
hsct
second
relaps
pulmonari
gastric
involv
patient
underw
allogen
bone
marrow
transplant
condit
regimen
combin
highdos
cyclophosphamid
fludarabin
initi
condit
regimen
present
bilater
knee
arthriti
sampl
joint
fluid
test
posit
aspergillu
fumigatu
patient
treat
amphotericin
b
mgkg
per
day
four
day
transplant
rapidli
progress
respiratori
failur
develop
lead
hospit
icu
admiss
physic
examin
reveal
acut
respiratori
distress
tachypnea
breathsmin
bilater
crackl
oxygen
satur
breath
highconcentr
oxygen
mask
shock
heart
rate
beat
min
blood
pressur
mm
hg
dissemin
mottl
arteri
blood
gase
obtain
breath
oxygen
highconcentr
oxygen
mask
rate
lmin
follow
ph
partial
pressur
carbon
dioxid
kpa
partial
pressur
oxygen
kpa
bicarbon
mmoll
laboratori
find
reveal
pancytopenia
wbc
count
cellsmm
hemoglobin
gdl
platelet
count
plateletsmm
acut
renal
failur
creatinin
level
mmoll
inflammatori
syndrom
creactiv
protein
mgl
fibrinogen
gl
chest
radiograph
reveal
dissemin
alveolar
interstiti
opac
patient
condit
deterior
rapidli
requir
endotrach
intub
mechan
ventil
result
test
perform
tracheobronchi
secret
sampl
posit
fumigatu
lead
treatment
combin
therapi
voriconazol
caspofungin
initi
improv
clinic
characterist
radiolog
find
bone
marrow
recoveri
patient
respiratori
condit
worsen
bilater
alveolar
opac
appear
chest
radiograph
result
blood
test
aspergillu
galactomannan
cmv
antigen
remain
neg
specimen
obtain
bal
perform
lingular
region
hemorrhag
find
quantit
cytolog
examin
noncontribut
numer
lyse
cell
find
extens
research
detect
presenc
microorgan
bacteria
mycobacteria
fungi
parasit
cmv
rsv
neg
despit
aggress
support
care
mechan
ventil
fluid
resuscit
highdos
norepinephrin
infus
refractori
hypoxia
rapidli
led
fatal
multiorgan
failur
autopsi
perform
cultur
bal
fluid
specimen
remain
neg
bacteria
mycobacteria
fungi
procedur
viral
cultur
rtpcr
appli
case
studi
describ
result
inocul
test
perform
cell
also
posit
reveal
coronalik
particl
subsequ
identifi
coronaviru
rtpcr
perform
cultur
supernat
bal
fluid
specimen
case
major
fact
led
diagnosi
coronaviru
pneumonia
first
exclus
altern
infecti
etiolog
second
identif
coronaviru
bal
fluid
sampl
combin
cultur
electron
microscopi
rtpcr
case
first
patient
main
differenti
diagnosi
vzvassoci
pneumonia
frequent
complic
varicella
adult
usual
concomit
cutan
vesicl
howev
respiratori
symptom
appear
complet
antivir
treatment
improv
skin
erupt
viral
cultur
pcr
vzv
perform
bal
fluid
specimen
neg
coronaviru
seroconvers
retrospect
confirm
diagnosi
second
patient
present
sever
acut
respiratori
failur
led
fatal
multiorgan
failur
despit
maxim
life
support
ventilatorassoci
pneumonia
frequent
complic
patient
receiv
mechan
ventil
associ
high
mortal
rate
especi
among
bone
marrow
recipi
bacteri
etiolog
larg
predomin
ventilatorassoci
pneumonia
cmv
identifi
possibl
caus
adult
patient
outbreak
coronavirusand
adenovirusrel
pneumonia
pediatr
icu
describ
case
describ
though
neg
result
bacteriolog
cultur
exclud
bacteri
origin
secondari
identif
coronaviru
bal
fluid
specimen
provid
high
probabl
diagnosi
viral
origin
accur
variou
method
detect
coronavirus
exist
lack
sensit
specif
use
routin
screen
respiratori
sampl
method
includ
identif
coronalik
particl
immunofluoresc
assay
monoclon
antibodi
rna
hybrid
fluid
specimen
nasal
wash
bal
detect
seroconvers
base
elisa
find
may
use
allow
rapid
virusidentif
provid
retrospect
diagnosi
identifi
coronaviru
patient
bal
specimen
cultur
human
hepatoma
cell
line
express
specif
receptor
coronavirus
recent
advanc
virolog
detect
method
molecular
amplif
techniqu
offer
promis
perspect
detect
coronavirus
inde
improv
sensit
specif
obtain
molecular
detect
method
combin
rtpcr
strainspecif
primer
deriv
protein
gene
follow
molecular
hybrid
specif
probe
recogn
either
coronaviru
invers
high
sensit
amplif
method
may
lead
falseposit
result
caus
contamin
bal
fluid
specimen
pharyng
virus
therefor
combin
viral
cultur
rtpcr
bal
fluid
sampl
appear
effici
reliabl
diagnost
strategi
two
coronaviru
strain
previous
relat
human
diseas
variou
clinic
syndrom
rang
selfresolv
common
cold
pneumonia
recent
worldwid
outbreak
sar
link
novel
coronaviru
previous
identifi
human
be
anim
clinic
featur
sar
combin
flulik
symptom
dri
cough
short
breath
associ
pulmonari
infiltr
visibl
chest
radiographi
contrast
common
benign
symptom
coronaviru
infect
healthi
individu
larg
proport
patient
sar
sever
respiratori
failur
requir
ventilatori
support
icu
impact
respiratori
viru
individu
larg
determin
underli
condit
particularli
whether
experienc
immunosuppress
preval
coronaviru
pulmonari
infect
among
immunocompromis
patient
unknown
probabl
larg
underestim
absenc
routin
perform
sensit
cell
cultur
rtpcr
electron
microscopi
bal
fluid
specimen
howev
rtpcr
result
neg
coronavirus
bal
sampl
hsct
recipi
acut
pulmonari
infiltr
thu
case
coronavirusassoci
pneumonia
previous
describ
immunocompromis
patient
follow
autolog
bone
marrow
transplant
diagnosi
base
presenc
viral
particl
bal
fluid
specimen
identif
coronaviru
highrisk
immunocompromis
patient
may
lead
earli
adopt
specif
therapeut
strategi
absenc
proof
efficaci
antivir
drug
treatment
remain
symptomat
circumst
differ
type
ifn
display
antivir
properti
coronavirus
may
evalu
